Washington Trust’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-210
| Closed | -$23.8K | – | 755 |
|
|
2025
Q1 | $23.8K | Hold |
210
| – | – | ﹤0.01% | 504 |
|
|
2024
Q4 | $22.2K | Hold |
210
| – | – | ﹤0.01% | 565 |
|
|
2024
Q3 | $22.7K | Sell |
210
-236
| -53% | -$25.8K | ﹤0.01% | 564 |
|
|
2024
Q2 | $48.4K | Sell |
446
-227
| -34% | -$26.8K | ﹤0.01% | 454 |
|
|
2024
Q1 | $88.8K | Sell |
673
-235
| -26% | -$29.4K | ﹤0.01% | 372 |
|
|
2023
Q4 | $111K | Sell |
908
-1,200
| -57% | -$134K | ﹤0.01% | 324 |
|
|
2023
Q3 | $237K | Sell |
2,108
-1,227
| -37% | -$156K | 0.01% | 227 |
|
|
2023
Q2 | $486K | Sell |
3,335
-3,210
| -49% | -$436K | 0.02% | 181 |
|
|
2023
Q1 | $846K | Sell |
6,545
-2,318
| -26% | -$291K | 0.04% | 148 |
|
|
2022
Q4 | $1.13M | Sell |
8,863
-4,864
| -35% | -$564K | 0.05% | 134 |
|
|
2022
Q3 | $1.44M | Sell |
13,727
-64,013
| -82% | -$7.02M | 0.07% | 116 |
|
|
2022
Q2 | $8.17M | Sell |
77,740
-725
| -0.9% | -$86K | 0.38% | 85 |
|
|
2022
Q1 | $10M | Buy |
78,465
+3,517
| +5% | +$424K | 0.4% | 86 |
|
|
2021
Q4 | $9.24M | Buy |
74,948
+1,418
| +2% | +$186K | 0.35% | 87 |
|
|
2021
Q3 | $10.4M | Buy |
73,530
+852
| +1% | +$125K | 0.29% | 99 |
|
|
2021
Q2 | $11.3M | Sell |
72,678
-138
| -0.2% | -$22.4K | 0.32% | 95 |
|
|
2021
Q1 | $11.3M | Sell |
72,816
-786
| -1% | -$122K | 0.35% | 92 |
|
|
2020
Q4 | $11M | Buy |
73,602
+1,735
| +2% | +$245K | 0.36% | 90 |
|
|
2020
Q3 | $9.5M | Buy |
71,867
+470
| +0.7% | +$61.4K | 0.35% | 91 |
|
|
2020
Q2 | $8.1M | Sell |
71,397
-54
| -0.1% | -$6.22K | 0.34% | 91 |
|
|
2020
Q1 | $7.01M | Buy |
71,451
+542
| +0.8% | +$71K | 0.33% | 89 |
|
|
2019
Q4 | $10.3M | Sell |
70,909
-331
| -0.5% | -$45.7K | 0.41% | 85 |
|
|
2019
Q3 | $9.56M | Sell |
71,240
-102
| -0.1% | -$13.2K | 0.51% | 71 |
|
|
2019
Q2 | $8.15M | Sell |
71,342
-3,905
| -5% | -$457K | 0.45% | 75 |
|
|
2019
Q1 | $8.95M | Sell |
75,247
-189
| -0.3% | -$21.5K | 0.5% | 70 |
|
|
2018
Q4 | $7.6M | Sell |
75,436
-3,557
| -5% | -$400K | 0.48% | 70 |
|
|
2018
Q3 | $10.1M | Sell |
78,993
-5,174
| -6% | -$615K | 0.54% | 66 |
|
|
2018
Q2 | $9.11M | Sell |
84,167
-4,236
| -5% | -$461K | 0.49% | 72 |
|
|
2018
Q1 | $9.36M | Sell |
88,403
-7,193
| -8% | -$835K | 0.55% | 65 |
|
|
2017
Q4 | $11.2M | Buy |
95,596
+3,768
| +4% | +$426K | 0.63% | 57 |
|
|
2017
Q3 | $10.4M | Sell |
91,828
-3,372
| -4% | -$389K | 0.62% | 58 |
|
|
2017
Q2 | $11.9M | Buy |
95,200
+1,203
| +1% | +$143K | 0.72% | 50 |
|
|
2017
Q1 | $11.1M | Buy |
93,997
+9,023
| +11% | +$1.02M | 0.71% | 51 |
|
|
2016
Q4 | $8.51M | Sell |
84,974
-13,578
| -14% | -$1.46M | 0.55% | 64 |
|
|
2016
Q3 | $12.4M | Buy |
+98,552
| New | +$12.2M | 0.82% | 51 |
|
Other funds holding ZBH
Washington Trust's ZBH Position: Q2 2025 in Review
Washington Trust sold out of Zimmer Biomet (ZBH) in Q2 2025, closing a stake of 210 shares — an estimated $23.8K sold.
Washington Trust first reported a position in ZBH in Q3 2016 and held it in 35 quarters. The position peaked at $12.4M in Q3 2016. 934 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.
- Washington Trust reported no remaining Zimmer Biomet position as of Q2 2025 after selling out during the quarter.
- Washington Trust sold 210 Zimmer Biomet shares in Q2 2025, an estimated $23.8K.
- Washington Trust first reported a position in Zimmer Biomet in Q3 2016 and held it in 35 quarters.
- Washington Trust's Zimmer Biomet position peaked at $12.4M in Q3 2016.
- 934 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.
Based on Washington Trust's 13F filing for Q2 2025, filed 8 Aug 2025.